Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 15.38.
Forward PE Ratio (15.38) = Close Price ($834.04) / Consensus Forward EPS ($54.24)
FORWARD PE RATIO
15.38
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-22.77%
vs the sector median at left
Regeneron Pharmaceuticals, Inc.
Market Cap
$85.92B
Forward PE Ratio
15.38
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $85.92B | 15.38 |
| Elevance Health Inc. (ELV)vs › | $86.86B | 14.75 |
| HCA Healthcare, Inc. (HCA)vs › | $92.92B | 14.54 |
| Boston Scientific Corporation (BSX)vs › | $74.87B | 15.25 |
| Cigna Corporation (CI)vs › | $73.33B | 9.10 |
| McKesson Corporation (MCK)vs › | $100.56B | 22.02 |
| GSK plc (GSK)vs › | $105.00B | 14.65 |
| Cencora, Inc. (COR)vs › | $61.88B | 17.79 |
| Moderna, Inc. (MRNA)vs › | $57.59B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $53.75B | 21.30 |
Trailing P/E
20.6
reported TTM EPS
Forward P/E
15.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $54.24 implies +34.2% EPS growth vs the reported trailing $40.43.
At today's $834.04 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| Fiscal year end |
|---|
| Consensus EPS |
|---|
| Estimate range |
|---|
| Analysts |
|---|
| Implied P/E |
|---|
| 2026-12-31 | $54.24 | $44.34 – $59.57 | 16 | 15.4x |
| 2027-12-31 | $60.88 | $47.06 – $68.41 | 10 | 13.7x |
| 2028-12-31 | $68.03 | $60.70 – $77.67 | 8 | 12.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
